I agree that this site is using cookies. You can find further informations here.
X
Zheng Quan Toh
95  results:
OpenAccess-fulltext X
Search for persons X
?
1

Editorial: HPV natural history, immunological responses and..:

Zheng Quan Toh ; Fanghui Zhao ; Lei Zhang..
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1349664/full.  , 2024
Link: https://doi.org/10.3389/..
 
?
2

DataSheet_1_Immunogenicity and reactogenicity of repeated i..:

Prasert Assantachai ; Suvimol Niyomnaitham ; Zheng Quan Toh...
doi:10.3389/fimmu.2023.1302041.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
3

DataSheet_1_Immunogenicity and reactogenicity of repeated i..:

Prasert Assantachai ; Suvimol Niyomnaitham ; Zheng Quan Toh...
doi:10.3389/fimmu.2023.1302041.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
4

Immunogenicity and reactogenicity of repeated intradermal m..:

Prasert Assantachai ; Suvimol Niyomnaitham ; Zheng Quan Toh...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1302041/full.  , 2024
Link: https://doi.org/10.3389/..
 
?
5

Immunogenicity and reactogenicity of accelerated regimens o..:

Suvimol Niyomnaitham ; Suparat Atakulreka ; Patimaporn Wongprompitak...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.1080791/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
6

DataSheet_1_Immunogenicity and reactogenicity of accelerate..:

Suvimol Niyomnaitham ; Suparat Atakulreka ; Patimaporn Wongprompitak...
doi:10.3389/fimmu.2022.1080791.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
7

Immunogenicity and reactogenicity of heterologous COVID-19 ..:

Chenchit Chayachinda ; Kanokwaroon Watananirun ; Chayawat Phatihattakorn...
http://dx.doi.org/10.1080/21645515.2023.2228670.  , 2023
Link: https://doi.org/10.1080/..
 
?
8

Image_1_Safety and immunogenicity of intradermal administra..:

Somruedee Chatsiricharoenkul ; Suvimol Niyomnaitham ; Harry Joshua Posen...
doi:10.3389/fimmu.2022.1010835.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
9

Immunogenicity and reactogenicity against the SARS-CoV-2 va..:

Suvimol Niyomnaitham ; Zheng Quan Toh ; Patimaporn Wongprompitak...
http://dx.doi.org/10.1080/21645515.2022.2091865.  , 2022
Link: https://doi.org/10.1080/..
 
?
10

Table_1_Safety and immunogenicity of intradermal administra..:

Somruedee Chatsiricharoenkul ; Suvimol Niyomnaitham ; Harry Joshua Posen...
doi:10.3389/fimmu.2022.1010835.s004.  , 2022
Link: https://doi.org/10.3389/..
 
?
11

Safety and immunogenicity of intradermal administration of ..:

Somruedee Chatsiricharoenkul ; Suvimol Niyomnaitham ; Harry Joshua Posen...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.1010835/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
12

Image_2_Safety and immunogenicity of intradermal administra..:

Somruedee Chatsiricharoenkul ; Suvimol Niyomnaitham ; Harry Joshua Posen...
doi:10.3389/fimmu.2022.1010835.s002.  , 2022
Link: https://doi.org/10.3389/..
 
?
13

Evaluation of the Safety and Immunogenicity of Fractional I..:

Suvimol Niyomnaitham ; Somruedee Chatsiricharoenkul ; Zheng Quan Toh...
COVID-19 Vaccines and Vaccination.  , 2022
Link: https://doi.org/10.3390/..
 
?
14

Evaluation of the Safety and Immunogenicity of Fractional I..:

Suvimol Niyomnaitham ; Somruedee Chatsiricharoenkul ; Zheng Quan Toh...
https://www.mdpi.com/2076-393X/10/9/1497.  , 2022
Link: https://doi.org/10.3390/..
 
?
15

Table_2_Safety and immunogenicity of intradermal administra..:

Somruedee Chatsiricharoenkul ; Suvimol Niyomnaitham ; Harry Joshua Posen...
doi:10.3389/fimmu.2022.1010835.s005.  , 2022
Link: https://doi.org/10.3389/..
 
1-15